<code id='31CE36590F'></code><style id='31CE36590F'></style>
    • <acronym id='31CE36590F'></acronym>
      <center id='31CE36590F'><center id='31CE36590F'><tfoot id='31CE36590F'></tfoot></center><abbr id='31CE36590F'><dir id='31CE36590F'><tfoot id='31CE36590F'></tfoot><noframes id='31CE36590F'>

    • <optgroup id='31CE36590F'><strike id='31CE36590F'><sup id='31CE36590F'></sup></strike><code id='31CE36590F'></code></optgroup>
        1. <b id='31CE36590F'><label id='31CE36590F'><select id='31CE36590F'><dt id='31CE36590F'><span id='31CE36590F'></span></dt></select></label></b><u id='31CE36590F'></u>
          <i id='31CE36590F'><strike id='31CE36590F'><tt id='31CE36590F'><pre id='31CE36590F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:9948
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          In key trial, Verve's treatment lowers cholesterol levels in patients
          In key trial, Verve's treatment lowers cholesterol levels in patients

          APStockVerveTherapeuticssaidSundaythatthefirst10peopletoreceiveaone-timetreatmentpoweredbyaformofCRI

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          As billionaires fund anti

          Metformin,adrugthatwasapprovedinthe’90sfortreatingdiabetes,wasshowninepidemiologicalstudiestoprevent